Surveillance for transfusion-transmitted viral infections in the United States. NLM AIDSLINE Important note: Information in this article was accurate in 1999. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Surveillance for transfusion-transmitted viral infections in the United States.

Biologicals. 1998 Jun;26(2):85-8. Unique Identifier : AIDSLINE MED/99030777
Chamberland ME; Centers for Disease and Prevention, Division of Viral and; Rickettsial Diseases, Atlanta, GA 30333, USA.

Abstract: Surveillance is part of a multi-faceted programme to monitor the safety of the U. S. blood supply. The Centers for Disease Control and Prevention administers several national surveillance programmes, including pathogen- and disease-specific systems (e.g. human immunodeficiency virus, hepatitis) and programmes that focus on donors and recipients of blood and plasma products (e.g. persons with haemophilia). Data collected in these systems can be used to monitor temporal and epidemiological trends, identify risk factors for infection, facilitate identification and investigation of potential outbreaks, and evaluate intervention and prevention strategies. Copyright 1998 The International Association of Biological Standardization
Keywords: JOURNAL ARTICLE Blood Donors Blood Transfusion/*ADVERSE EFFECTS Centers for Disease Control and Prevention (U.S.) Creutzfeldt-Jakob Syndrome/EPIDEMIOLOGY/PREVENTION & CONTROL/ TRANSMISSION Disease Outbreaks/PREVENTION & CONTROL Hemophilia A/EPIDEMIOLOGY/THERAPY Hepatitis, Viral, Human/EPIDEMIOLOGY/PREVENTION & CONTROL/ TRANSMISSION Human HIV Infections/EPIDEMIOLOGY/PREVENTION & CONTROL/TRANSMISSION Risk Factors Safety United States/EPIDEMIOLOGY Virus Diseases/EPIDEMIOLOGY/*PREVENTION & CONTROL/*TRANSMISSIONKWDjournalarticleblooddonorsbloodtransfusion/KWDadverseeffectscentersfordiseasecontrolandprevention(uKWDs
990228
A9920927

Copyright © 1999 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1999. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1999. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .